Mori, Yusaku <br/><br/>
Ezetimibe alone or in combination with pitavastatin prevents kidney dysfunction in 5/6 nephrectomized rats fed high-cholesterol.  [electronic resource] 

 -  Metabolism: clinical and experimental  Mar 2012 
 - 379-88 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1532-8600 
<br/><br/><label>Standard No.: </label>10.1016/j.metabol.2011.07.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Anticholesteremic Agents--therapeutic use<br/>Antigens, CD--metabolism<br/>Antigens, Differentiation, Myelomonocytic--metabolism<br/>Azetidines--therapeutic use<br/>Cholesterol--blood<br/>Cholesterol, Dietary--pharmacology<br/>Cholesterol, HDL--blood<br/>Creatinine--metabolism<br/>Deoxyguanosine--metabolism<br/>Ezetimibe<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--therapeutic use<br/>Immunohistochemistry<br/>Kidney--pathology<br/>Kidney Diseases--etiology<br/>Kidney Function Tests<br/>Male<br/>Nephrectomy<br/>Proteinuria--metabolism<br/>Quinolines--therapeutic use<br/>RNA--biosynthesis<br/>Rats<br/>Rats, Wistar<br/>Real-Time Polymerase Chain Reaction<br/>Triglycerides--blood